🔴 Femasys is trading 10.3% down today amid falling indexes and rising oil

Femasys is trading at $1.48, down 10.30%, amid broad-market pressure, with no clear company-specific catalyst identified.

• No new company-specific announcement was identified for October 22; the SandsRx partnership was announced October 20.
• Major indexes are down, while reports of Strait of Hormuz tanker incidents have pushed oil higher.
• Available evidence points to broad-market pressure, but does not establish that the market move alone caused the decline.